Lifescience Global

Executive Editor- Profile

Sandeep Kumar VashistSandeep Kumar Vashist Ph.D.

Current Status
Head of Immunodiagnostics
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. (HSG-IMIT)
Georges-Koehler-Allee 103
79110 Freiburg, GERMANY

Sandeep K. Vashist is the Head of Immunodiagnostics at HSG-IMIT, Germany, where he is working on the development of clinically-relevant diagnostic kits, bioanalytical sciences and lab-on-a-chip technology. He completed his doctorate on BioMEMS-based microdiagnostic kit from Central Scientific Instruments Organisation, India in 2006. From 2006-2009, he worked as a Scientist in Bioanalytical Sciences at Bristol-Myers Squibb Pharmaceutical Company, Ireland, where he developed bioanalytical platforms and technologies for the rapid detection of biopharmaceutical analytes and disease biomarkers. Thereafter, from 2009-2012, he was the Team Leader at NUS Nanoscience and Nanotechnology Initiative, Singapore, where he developed several proprietary technologies for diabetic monitoring. He has successfully accomplished many technology transfers (>25) to industries and healthcare; published extensively in topmost high impact-factor (IF) journals (like Nature Protocols, Anal Chem, Anal Biochem, Analyst, Carbon, Talanta, Biotech Adv, Biosens Bioelectron); filed several patents; and, presented at highly prestigious conferences. He has constantly received many international awards from renowned institutions such as University of Leeds, UK; awarded for scientific research excellence, innovation and performance; bestowed with invited membership of RCS; and, received highly prestigious research fellowships. He is the international expert and reviewer for more than 36 journals (with IF ranging from 4 to 41; in the fields of bioanalytical sciences, biochemistry, diagnostics, biosensors, point-of-care devices, analytical chemistry, nanotechnology and lab-on-a-chip technology) and many funding agencies.

 

 

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

OUR STRENGTHS

♦  Worldwide readership
♦  High quality content
♦  Maximum visibility
♦  Efficient publishing
♦  Optional Open Access

Publish your Research

Survey

As an author what type of publishing model you prefer?

780
Open Access
493
Optional Open Access
338
Subscription based
5 Votes left